GlassScriptPhysician profile
Rachel Talis
NPI 1184605040
$2,145.39
in general payments reported to CMS, 2019-2025
12 companies · $255 in 2025
The $255 reported for 2025 was more than what 81% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,142 · 2020: $12.17 · 2021: $113 · 2022: $420 · 2023: $160 · 2024: $43.58 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346 · Gift: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.89 |
| Gift | $112.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Benco Dental Supply Co. | $830.62 | 2019 | |
| Ultradent Products INC | $592.23 | 2021-2025 | Opalescence |
| Revance Therapeutics, INC. | $217.08 | 2025 | Daxxify |
| Galderma Laboratories, L.P. | $175.67 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $76.45 | 2019 | |
| Straumann USA LLC | $73.96 | 2022 | |
| Dentsply Sirona INC | $50.57 | 2022-2025 | Waveone Gold Conform Fit |
| Keystone Dental INC. | $47.24 | 2019 | |
| Implant Direct Sybron International LLC | $38.36 | 2019 | |
| Philips North America LLC | $14.83 | 2024 | (E55) Oral Health Care Und |
| Nobel Biocare USA | $14.19 | 2023 | Nobelactive |
| Kerr Corporation | $14.19 | 2023 | Harmonize |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Talis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.